NEW YORK, Sept. 22, 2024 /PRNewswire/ — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Progyny, Inc. (“Progyny” or “the Company”) (NASDAQ: PGNY). Investors who purchased Progyny securities are encouraged to obtain…

NEW YORK, Sept. 22, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds purchasers of Pre-IPO shares through funds issued by Late Stage Asset Management, LLC between March 2019 and March 2023, both dates inclusive (the “Class Period”), of the important…

– HANSIZHUANG ® (Serplulimab) war der erste monoklonale Anti-PD-1-Antikörper (mAb), der für die Erstlinienbehandlung von ES-SCLC zugelassen wurde – HETRONIFLY® (Serplulimab) wird voraussichtlich der erste monoklonale Anti-PD-1-Antikörper sein, der in Europa für die Erstlinienbehandlung…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.